These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7602477)

  • 1. An evaluation of the mechanisms of drug release from glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 Mar; 47(3):182-7. PubMed ID: 7602477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S; El Massik MA; Abdallah OY; Daabis NA
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 May; 47(5):355-9. PubMed ID: 7494182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and in vitro evaluation of a novel vaginal drug delivery system based on gelucire.
    Geeta MP; Madhabhai MP
    Curr Drug Deliv; 2009 Apr; 6(2):159-65. PubMed ID: 19450222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules.
    Ratsimbazafy V; Bourret E; Duclos R; Brossard C
    Eur J Pharm Biopharm; 1999 Nov; 48(3):247-52. PubMed ID: 10612036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of release from selected thermosoftening vehicles.
    Kopcha M; Lordi NG; Tojo KJ
    J Pharm Pharmacol; 1991 Jun; 43(6):382-7. PubMed ID: 1681048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moisture uptake of polyoxyethylene glycol glycerides used as matrices for drug delivery: kinetic modelling and practical implications.
    Qi S; Belton P; McAuley W; Codoni D; Darji N
    Pharm Res; 2013 Apr; 30(4):1123-36. PubMed ID: 23229859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on the release of salbutamol sulfate from lipid matrices.
    San Vicente A; Hernández RM; Gascón AR; Calvo MB; Pedraz JL
    Int J Pharm; 2000 Nov; 208(1-2):13-21. PubMed ID: 11064207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of formulation on the rheology of theophylline compound suspensions in Gelucires.
    Ratsimbazafy V; Bourret E; Brossard C
    J Pharm Pharmacol; 1997 Sep; 49(9):852-7. PubMed ID: 9306251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability of Gelucire 50/13 for controlled release formulation of salbutamol sulphate.
    Mohsin S; Rahman NU; Idrees MA; Sarfraz MK; Khan MK; Mustafa G
    Pak J Pharm Sci; 2012 Jan; 25(1):35-41. PubMed ID: 22186307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of physical and chemical properties on drug release from selected thermosoftening vehicles.
    Kopcha M; Lordi NG
    J Pharm Pharmacol; 1992 Feb; 44(2):79-83. PubMed ID: 1352821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.
    da Fonseca Antunes AB; De Geest BG; Vervaet C; Remon JP
    Drug Dev Ind Pharm; 2013 May; 39(5):791-8. PubMed ID: 22871141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on biological macromolecules lipid-Gelucire based gastroretentive multiparticulate.
    Upadhyay P; Pandit JK; Wahi AK
    Int J Biol Macromol; 2014 Jun; 67():463-77. PubMed ID: 24699418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of lipid matrix aging on in vitro release and in vivo bioavailability.
    Choy YW; Khan N; Yuen KH
    Int J Pharm; 2005 Aug; 299(1-2):55-64. PubMed ID: 15955645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drug incorporation on the structure and release properties of solid dispersions in lipid matrices.
    Khan N; Craig DQ
    J Control Release; 2003 Dec; 93(3):355-68. PubMed ID: 14644585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of polyglycolized glycerides in protection of amorphous form of etoricoxib during compression.
    Shimpi S; Mahadik K; Takada K; Paradkar A
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1448-51. PubMed ID: 17917287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
    Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
    AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.